Comparison between testosterone oenanthate-induced azoospermia and oligozoospermia in a male contraceptive study. IV. Suppression of endogenous testicular and adrenal androgens.
Administration of supraphysiological doses of testosterone to normal men causes inhibition of spermatogenesis, but while most become azoospermic, 30-55% maintain a low rate of spermatogenesis. We have investigated whether there are differences in endogenous androgen production, of testicular and adrenal origin, which may be related to the degree of suppression of spermatogenesis. Thirty-three healthy Caucasian men were given weekly i.m. injections of 200 mg testosterone oenanthate (TE), 18 became azoospermic, while 15 remained oligozoospermic. Urinary excretion of epitestosterone, a specific testicular product, was reduced to <10% of pretreatment values, with no differences between the groups. Similar results were obtained for other markers of testicular steroidogenesis. Urinary and plasma adrenal androgens were also reduced during TE treatment: a statistically significant decrease in both (P < 0.001 and P < 0.05 respectively) was seen in the azoospermic but not oligozoospermic responders. These results suggest that testicular steroidogenesis is decreased to <10% by the administration of supraphysiological doses of exogenous testosterone. Differences in the degree of ongoing steroidogenesis in the testis do not appear to account for incomplete suppression of spermatogenesis, thus differences in androgen metabolism may underlie this heterogeneous response. A small but significant reduction in secretion of adrenal androgens was also detectable, the relevance of which is unclear.
Anderson
R A
RA
Department of Obstetrics and Gynaecology, University of Edinburgh, Centre for Reproductive Biology, UK.
Wallace
A M
AM
Kicman
A T
AT
Wu
F C
FC
D000305:Adrenal Cortex Hormones / Q000378:metabolism; D000328:Adult; D000728:Androgens / Q000097:blood / Q000378:metabolism* / Q000652:urine; D003272:Contraceptive Agents, Male / Q000627:therapeutic use*; D003864:Depression, Chemical; D004845:Epitestosterone / Q000378:metabolism; D005938:Glucocorticoids / Q000378:metabolism; D006801:Humans; D008297:Male; D009845:Oligospermia / Q000139:chemically induced*; D013076:Sperm Count / Q000187:drug effects; D013739:Testosterone / Q000031:analogs & derivatives* / Q000378:metabolism / Q000627:therapeutic use
D000305:Adrenal Cortex Hormones; D000728:Androgens; D003272:Contraceptive Agents, Male; D005938:Glucocorticoids; D013739:Testosterone; D004845:Epitestosterone; C004648:testosterone enanthate